ISC, CAS, Google Scholar     h-index: 20

Document Type : Original Research Article


Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan 200284, Nigeria


Previous studies have investigated the safety of the food/drug additive, 5-hydroxymethylfurfural including its albumin binding which might impact on its biodistribution and toxicity. In contrast, the safety assessment of its major degradant, di (5-furfural) ether (OMBF) is often neglected despite having been detected at concentrations in excess of HMF in parenteral solutions. The aim of this study was to compare the albumin binding characteristics of OMBF with 5-hydroxymethylfurfural. OMBF was synthesized by thermal dehydration of 5-hydroxymethylfurfural and characterized by using spectroscopic and mass spectral techniques. The binding characteristics of 5-hydroxymethylfurfural and OMBF with bovine serum albumin (BSA) were elucidated by using UV-visible spectroscopy, molecular docking, and semi-empirical calculations.
Photometric titrations with OMBF revealed more pronounced perturbations in the UV-visible spectra of BSA and binding constants that were 51% greater than those of 5-hydroxymethylfurfural. Thermodynamic parameters revealed that the OMBF binding to albumin was spontaneous and hydrophobic interactions were the main forces responsible for complex stabilization. Docking studies showed that the superior binding affinity of OMBF was due to its higher C/H ratio which facilitated an extensive network of six hydrophobic interactions with Tyr149, Leu237, Ala290, Ile289, and Arg194 residues of BSA Site I compared with only two hydrophobic interactions in 5-hydroxymethylfurfural complex. Analysis of the multi-point hydrogen bonded complexes by using PM6-D3H+ method revealed the interaction energy of OMBF-BSA complex was 1.5 folds greater than 5-hydroxymethylfurfural-BSA.
The study confirmed an increased avidity and stability in the complexation of albumin with OMBF compared with 5-hydroxymethylfurfural. Stricter limits control of OMBF in heat-processed foods/drugs is necessary

Graphical Abstract

Spectroscopic, Molecular Docking and Semi-Empirical Studies of the Albumin Binding Activities of 5-Hydroxymethylfurfural and its Synthesized Derivative, Di (5-Furfural) Ether


Main Subjects

[1]          F.J. Morales, Hydroxymethylfurfural (HMF) and related compounds, in: R.. Stadler, D.R. Lineback (Eds.), Process-Induced Food Toxicants: Occurrence, Formation, Mitigation, and Health Risks, John Wiley and Sons, Inc., New Jersey, (2009) 135–174.
[2]          K. Abraham, R. Gürtler, K. Berg, G. Heinemeyer, A. Lampen, K.E. Appel, Toxicology and risk assessment of 5-Hydroxymethylfurfural in food, Mol. Nutr. Food Res., 55 (2011) 667–678.
[3]          N. Lin, T. Liu, L. Lin, S. Lin, Q. Zang, J. He, Z. Abliz, C. Li, A. Wang, H. Jin, Comparison of in vivo immunomodulatory effects of 5-hydroxymethylfurfural and 5, 5′-oxydimethylenebis (2-furfural), Regul. Toxicol. Pharmacol., 81 (2016) 500–511.
[4]          M.R. Farag, M. Alagawany, M. Bin-Jumah, S.I. Othman, A.F. Khafaga, H.M. Shaheen, D. Samak, A.M. Shehata, A.A. Allam, M.E. Abd El-Hack, The toxicological aspects of the heat-borne toxicant 5-hydroxymethylfurfural in animals: A review, Molecules, 25 (2020) 1–13.
[5]          U.M. Shapla, M. Solayman, N. Alam, M.I. Khalil, S.H. Gan, 5-Hydroxymethylfurfural (HMF) levels in honey and other food products: effects on bees and human health, Chem. Cent. J., 12 (2018) 35.
[6]          I. Florin, L. Rutberg, M. Curvall, C.R. Enzell, Screening of tobacco smoke constituents for mutagenicity using the Ames’ test, Toxicology, 15 (1980) 219–232.
[7]          Y.C. Lee, M. Shlyankevich, H.-K. Jeong, J.S. Douglas, Y.J. Surh, Bioactivation of 5-hydroxymethyl-2-furaldehyde to an electrophilic and mutagenic allylic sulfuric acid ester, Biochem. Biophys. Res. Commun., 209 (1995) 996–1002.
[8]          H. Glatt, H. Schneider, Y. Liu, V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals, Mutat. Res. Toxicol. Environ. Mutagen., 580 (2005) 41–52.
[9]          A.H. Høie, C. Svendsen, G. Brunborg, H. Glatt, J. Alexander, W. Meinl, T. Husøy, Genotoxicity of three food processing contaminants in transgenic mice expressing human sulfotransferases 1A1 and 1A2 as assessed by the in vivo alkaline single cell gel electrophoresis assay, Environ. Mol. Mutagen., 56 (2015) 709–714.
[10]       L.J.K. Durling, L. Busk, B.E. Hellman, Evaluation of the DNA damaging effect of the heat-induced food toxicant 5-hydroxymethylfurfural (HMF) in various cell lines with different activities of sulfotransferases, Food Chem. Toxicol., 47 (2009) 880–884.
[11]       M. Guo, L. He, X.W. Lu, Binding mechanism of traditional Chinese medicine active component 5-hydroxymethyl-furfural and HSA or BSA, Yao Xue Xue Bao= Acta Pharm. Sin., 47 (2012) 385–392.
[12]       B. Chen, H. Luo, W. Chen, Q. Huang, K. Zheng, D. Xu, Pharmacokinetics, tissue distribution and Human serum albumin binding properties of Delicaflavone, a novel anti-tumor candidate, Front. Pharmacol., 12 (2021) 1–12.
[13]       O.E. Thomas, O.A. Adegoke, Toxicity of food colours and additives: A review, African J. Pharm. Pharmacol., 9 (2015) 900–914.
[14]       G. Arribas-Lorenzo, F.J. Morales, Estimation of dietary intake of 5-hydroxymethylfurfural and related substances from coffee to Spanish population, Food Chem. Toxicol., 48 (2010) 644–649.
[15]       B.F.M. Kuster, 5‐Hydroxymethylfurfural (HMF): a review focussing on its manufacture, Starch‐Stärke, 42 (1990) 314–321.
[16]       C. Larousse, L. Rigal, A. Gaset, Synthesis of 5, 5′‐Oxydimethylenebis (2‐furfural) by Thermal dehydration of 5‐Hydroxymethyl‐2‐furfural in the presence of Dimethylsulfoxide, J. Chem. Technol. Biotechnol., 53 (1992) 111–116.
[17]       C.E. Duru, I.A. Duru, A.E. Adegboyega, In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets, Bull. Natl. Res. Cent., 45:57 (2021).
[18]       J.C. Kromann, A.S. Christensen, C. Steinmann, M. Korth, J.H. Jensen, A third-generation dispersion and third-generation hydrogen bonding corrected PM6 method : PM6-D3H +, PeerJ, 2 (2014) e449.
[19]       M. Waller, S. Grimme, Weak intermolecular interactions: A supermolecular approach, in: L. Leszczynski (Ed.), Handbook of Computational Chemistry, Springer Science+Business Media, Berlin, (2012) 444–466.,.
[20]       A. Hashim, V. Poulose, T. Thiemann, One pot o-alkylation/Wittig olefination of hydroxybenzaldehydes in DMSO, Chem. Proc., (2021) 99.
[21]       M. Kazemia, Z. Noori, H. Kohzadi, M. Sayadia, A. Kazemia, A mild and efficient procedure for the synthesis of ethers from various alkyl halides, Q. J. Iran. Chem. Commun., 1 (2013) 43–50.
[22]       A.L. Koritzke, K.M. Frandsen, M.G. Christianson, J.C. Davis, A.C. Doner, A. Larsson, J. Breda-Nixon, B. Rotavera, Fragmentation mechanisms from electron-impact of complex cyclic ethers formed in combustion, Int. J. Mass Spectrom., 454 (2020) e116342.
[23]       O. Herbinet, S. Bax, P.-A. Glaude, V. Carré, F. Battin-Leclerc, Mass spectra of cyclic ethers formed in the low-temperature oxidation of a series of n-alkanes, Fuel, 90 (2011) 528–535.
[24]       S.D. Stojanović, J.M. Nićiforović, S.M. Živanović, J. V Odović, R.M. Jelić, Spectroscopic studies on the drug – drug interaction : the influence of fluoroquinolones on the affinity of tigecycline to human serum albumin and identification of the binding site, Monatshefte Für Chemie - Chem. Mon., 151 (2020) 999–1007.
[25]       N. Shahabadi, S.M. Fili, Molecular modeling and multispectroscopic studies of the interaction of mesalamine with bovine serum albumin, Spectrochim. Acta - Part A Mol. Biomol. Spectrosc., 118 (2014) 422–429.
[26]       M. Al Bratty, Spectroscopic and molecular docking studies for characterizing binding mechanism and conformational changes of human serum albumin upon interaction with Telmisartan, Saudi Pharm. J., 28 (2020) 729–736.
[27]       N. Shahabadi, S. Zendehcheshm, Evaluation of ct-DNA and HSA binding propensity of antibacterial drug chloroxine: Multi-spectroscopic analysis, atomic force microscopy and docking simulation, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 230 (2020) 118042.
[28]       S.M. Jankovic, S.D. Stojanovic, Interaction between tigecycline and human serum albumin in aqueous solution, Monatshefte Fur Chemie., 146 (2015) 399–409.
[29]       M. Khoder, H. Abdelkader, A. ElShaer, A. Karam, M. Najlah, R.G. Alany, Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin, Int. J. Pharm., 515 (2016) 740–748.
[30]       M. Schauperl, M. Podewitz, B.J. Waldner, K.R. Liedl, Enthalpic and entropic contributions to hydrophobicity, J. Chem. Theory Comput., (2016) 4600-4610.
[31]       S. Mukherjee, L.V. Schafer, Spatially resolved hydration thermodynamics in biomolecular systems, J Phys Chem B, 126 (2022) 3619–3631.
[32]       R.N. El Gammal, H. Elmansi, A.A. El Emam, F. Belal, M.E. Hammouda, Exploring the molecular interaction of mebendazole with bovine serum albumin using multi-spectroscopic approaches and molecular docking, Sci Rep., 12 (2022) 11582.
[33]       Z. Zhou, X. Hu, X. Hong, J. Zheng, X. Liu, D. Gong, G. Zhang, Interaction characterization of 5-hydroxymethyl-2-furaldehyde with human serum albumin: binding characteristics, conformational change and mechanism, J. Mol. Liq., (2019) 111835.
[34]       C. Pommié, S. Levadoux, R. Sabatier, G. Lefranc, M. Lefranc, IMGT standardized criteria for statistical analysis of immunoglobulin V‐REGION amino acid properties, J. Mol. Recognit., 17 (2004) 17–32.